The report published by Allied Market Research on the global dermal fillers market indicates that the industry was valued at $5.1 billion in 2021 and is expected to generate $14.4 billion at the end of 2031, with 10.8% CAGR from the year 2022 to 2031. The report provides an in-depth examination of evolving market trends, primary market segments, significant areas for investment, the value chain, regional overview, and the competitive situation. It serves as a valuable source of information for both established market leaders and newcomers, as well as for investors and stakeholders seeking to formulate future strategies and enhance their market position.
Request Sample of the Report on Dermal Filler Market Forecast 2032 – https://www.alliedmarketresearch.com/request-sample/7654
Recent Developments in the Dermal Filler Market
- In February 2022, AbbVie Inc., a global leader in the pharmaceutical industry received the Food and Drug Administration (FDA) approval for JUVEDERM VOLBELLA XC, which is the first dermal filler used for the treatment of infraorbital hollows in adults over 21 years old. This approval will help the company to expand its Aesthetics product portfolio.
- In February 2022, Merz Aesthetics, a global medical aesthetics company has launched its Radiesse Lidocaine injectable implant for soft tissue augmentation. It aims to improve moderate to severe loss of jawline contour in adults.
- In February 2021, Galderma, a pharmaceutical manufacturing company received the U.S. Food and Drug Administration (FDA) approval for its Restylane Defyne to augment and correct mild to moderate chin retrusion.
- In October 2020, AbbVie Inc., a global pharmaceutical company acquired the Luminera, a privately held, aesthetics company to enhance the international dermal filler portfolio, with its JUVEDERM collection of fillers. This Acquisition will help the company to gain strong Foothold in dermal fillers market.
Want to Explore More, Connect to our Analyst – https://www.alliedmarketresearch.com/connect-to-analyst/7654
The report provides an in-depth segmentation of the global dermal filler market on the basis of gender, service provider, type, and region. The report conducts an analysis of every segment and its sub-segments, utilizing visual aids such as tables and figures. This analysis is a valuable resource for market participants, investors, and those entering the market, assisting them in identifying the specific sub-segments that offer growth opportunities in the forthcoming years.
By type, the hyaluronic acid (HA) segment contributed to more than two-thirds of the global dermal filler market revenue in 2021 and is estimated to maintain its dominance throughout the forecast timeframe. Also, the same segment would cite a noteworthy CAGR of 11.1% from 2022 to 2031. The report also analyses the poly l lactic acid, calcium hydroxylapatite, and others segments.
When it’s come to gender category, the female segment accounted more than 90% of the market share in 2021 and estimated to lead the trail throughout the forecast timeframe. The same segment is expected to portray a notable CAGR of 10.8% during the forecast year. The male segment is also analyzed in the report.
Under the service provider category, the hospital segment grabbed the lion’s share in 2021 accounting for more than two-fifths of the overall market revenue and is estimated to retain its dominance by 2031. The same segment would display the highest CAGR of 11.1% during the forecast period.
For Procurement Information – https://www.alliedmarketresearch.com/purchase-enquiry/7654
The regional analysis in the report concludes that the North America region garnered the major share in 2021 accounting for nearly two-fifths of the global market and will lead the trail throughout the forecast timeframe. On the other hand, the market across Asia-Pacific is estimated to experience substantial growth with 11.8% CAGR during the forecast period. The other regions analyzed in the report are LAMEA and Europe.
Top players profiled in the global dermal fillers market are Vital Esthetique Laboratories, Teoxane Laboratories, Sinclair Pharma, Revance Therapeutics, MerzPharma GmbH and Co. KGaA, Galderma SA, Elan Aesthetics Inc., Bioxis Pharmaceutical, Cutera Inc., and AbbVie Laboratories.
The report offers an in-depth analysis of the major players in the global dermal filler market. These companies have employed a variety of strategies, including expansion, the introduction of new products, partnerships, and other initiatives, to enhance their market presence and strengthen their position within the industry. The report is a valuable resource for evaluating the operational segments, product offerings, business performance, and innovations undertaken by each market player.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
- Which region has more opportunities?
By Region Outlook
- North America
(U.S., Canada, Mexico)
- Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
- Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
- LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
